Global Pharmaceutical Contract Manufacturing (CMO) Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
ReportID: 710699
|
Published Date: 2024/07/06
|
No. of Pages: 165
|
Categories: Business & Financial Services
|
Format : 
The report focuses on the Pharmaceutical Contract Manufacturing (CMO) market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Pharmaceutical Contract Manufacturing (CMO) market.
Major Players in the Pharmaceutical Contract Manufacturing (CMO) market are:
Jubilant Life Sciences Limited
Aenova Group
Pfizer Inc.
Famar S.A.
Baxter BioPharma solutions
Patheon Inc
Boehringer Ingelheim International GmbH.
Catalent Inc.
Recipharm AB
On the basis of types, the Pharmaceutical Contract Manufacturing (CMO) market is primarily split into:
Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Development and Manufacturing
Secondary Packaging
On the basis of applications, the market covers:
Oncology
Central Nervous System
Cardiovascular Disorder
Infectious Diseases
Pulmonary Disorder
Metabolic Disorder
Gastrointestinal Disorder
Musculoskeletal Disorder
Genitourinary Disorder
Endocrinology
Others
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Pharmaceutical Contract Manufacturing (CMO) market.
Major Players in the Pharmaceutical Contract Manufacturing (CMO) market are:
Jubilant Life Sciences Limited
Aenova Group
Pfizer Inc.
Famar S.A.
Baxter BioPharma solutions
Patheon Inc
Boehringer Ingelheim International GmbH.
Catalent Inc.
Recipharm AB
On the basis of types, the Pharmaceutical Contract Manufacturing (CMO) market is primarily split into:
Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Development and Manufacturing
Secondary Packaging
On the basis of applications, the market covers:
Oncology
Central Nervous System
Cardiovascular Disorder
Infectious Diseases
Pulmonary Disorder
Metabolic Disorder
Gastrointestinal Disorder
Musculoskeletal Disorder
Genitourinary Disorder
Endocrinology
Others
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Pharmaceutical Contract Manufacturing (CMO) Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029
Chapter 1 Pharmaceutical Contract Manufacturing (CMO) Market Overview
1.1 Product Overview and Scope of Pharmaceutical Contract Manufacturing (CMO)
1.2 Pharmaceutical Contract Manufacturing (CMO) Market Segmentation by Type
1.2.1 Global Production Market Share of Pharmaceutical Contract Manufacturing (CMO) by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Pharmaceutical Contract Manufacturing (CMO) Market Segmentation by Application
1.3.1 Pharmaceutical Contract Manufacturing (CMO) Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Pharmaceutical Contract Manufacturing (CMO) Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Pharmaceutical Contract Manufacturing (CMO) (2014-2029)
Chapter 2 Global Economic Impact on Pharmaceutical Contract Manufacturing (CMO) Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global Pharmaceutical Contract Manufacturing (CMO) Market Competition by Manufacturers
3.1 Global Pharmaceutical Contract Manufacturing (CMO) Production and Share by Manufacturers (2020 and 2022)
3.2 Global Pharmaceutical Contract Manufacturing (CMO) Revenue and Share by Manufacturers (2020 and 2022)
3.3 Global Pharmaceutical Contract Manufacturing (CMO) Average Price by Manufacturers (2020 and 2022)
3.4 Manufacturers Pharmaceutical Contract Manufacturing (CMO) Manufacturing Base Distribution, Production Area and Product Type
3.5 Pharmaceutical Contract Manufacturing (CMO) Market Competitive Situation and Trends
3.5.1 Pharmaceutical Contract Manufacturing (CMO) Market Concentration Rate
3.5.2 Pharmaceutical Contract Manufacturing (CMO) Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global Pharmaceutical Contract Manufacturing (CMO) Production, Revenue (Value) by Region (2014-2022)
4.1 Global Pharmaceutical Contract Manufacturing (CMO) Production by Region (2014-2022)
4.2 Global Pharmaceutical Contract Manufacturing (CMO) Production Market Share by Region (2014-2022)
4.3 Global Pharmaceutical Contract Manufacturing (CMO) Revenue (Value) and Market Share by Region (2014-2022)
4.4 Global Pharmaceutical Contract Manufacturing (CMO) Production, Revenue, Price and Gross Margin (2014-2022)
4.5 North America Pharmaceutical Contract Manufacturing (CMO) Production, Revenue, Price and Gross Margin (2014-2022)
4.6 Europe Pharmaceutical Contract Manufacturing (CMO) Production, Revenue, Price and Gross Margin (2014-2022)
4.7 China Pharmaceutical Contract Manufacturing (CMO) Production, Revenue, Price and Gross Margin (2014-2022)
4.8 Japan Pharmaceutical Contract Manufacturing (CMO) Production, Revenue, Price and Gross Margin (2014-2022)
4.9 Southeast Asia Pharmaceutical Contract Manufacturing (CMO) Production, Revenue, Price and Gross Margin (2014-2022)
4.10 India Pharmaceutical Contract Manufacturing (CMO) Production, Revenue, Price and Gross Margin (2014-2022)
Chapter 5 Global Pharmaceutical Contract Manufacturing (CMO) Supply (Production), Consumption, Export, Import by Regions (2014-2022)
5.1 Global Pharmaceutical Contract Manufacturing (CMO) Consumption by Regions (2014-2022)
5.2 North America Pharmaceutical Contract Manufacturing (CMO) Production, Consumption, Export, Import by Regions (2014-2022)
5.3 Europe Pharmaceutical Contract Manufacturing (CMO) Production, Consumption, Export, Import by Regions (2014-2022)
5.4 China Pharmaceutical Contract Manufacturing (CMO) Production, Consumption, Export, Import by Regions (2014-2022)
5.5 Japan Pharmaceutical Contract Manufacturing (CMO) Production, Consumption, Export, Import by Regions (2014-2022)
5.6 Southeast Asia Pharmaceutical Contract Manufacturing (CMO) Production, Consumption, Export, Import by Regions (2014-2022)
5.7 India Pharmaceutical Contract Manufacturing (CMO) Production, Consumption, Export, Import by Regions (2014-2022)
Chapter 6 Global Pharmaceutical Contract Manufacturing (CMO) Production, Revenue (Value), Price Trend by Type
6.1 Global Pharmaceutical Contract Manufacturing (CMO) Production and Market Share by Type (2014-2022)
6.2 Global Pharmaceutical Contract Manufacturing (CMO) Revenue and Market Share by Type (2014-2022)
6.3 Global Pharmaceutical Contract Manufacturing (CMO) Price by Type (2014-2022)
6.4 Global Pharmaceutical Contract Manufacturing (CMO) Production Growth by Type (2014-2022)
Chapter 7 Global Pharmaceutical Contract Manufacturing (CMO) Market Analysis by Application
7.1 Global Pharmaceutical Contract Manufacturing (CMO) Consumption and Market Share by Application (2014-2022)
7.2 Global Pharmaceutical Contract Manufacturing (CMO) Consumption Growth Rate by Application (2014-2022)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 Pharmaceutical Contract Manufacturing (CMO) Manufacturing Cost Analysis
8.1 Pharmaceutical Contract Manufacturing (CMO) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Pharmaceutical Contract Manufacturing (CMO)
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Pharmaceutical Contract Manufacturing (CMO) Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Pharmaceutical Contract Manufacturing (CMO) Major Manufacturers in 2020
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global Pharmaceutical Contract Manufacturing (CMO) Market Forecast (2022-2029)
12.1 Global Pharmaceutical Contract Manufacturing (CMO) Production, Revenue Forecast (2022-2029)
12.2 Global Pharmaceutical Contract Manufacturing (CMO) Production, Consumption Forecast by Regions (2022-2029)
12.3 Global Pharmaceutical Contract Manufacturing (CMO) Production Forecast by Type (2022-2029)
12.4 Global Pharmaceutical Contract Manufacturing (CMO) Consumption Forecast by Application (2022-2029)
12.5 Pharmaceutical Contract Manufacturing (CMO) Price Forecast (2022-2029)
Chapter 13 Appendix
Chapter 1 Pharmaceutical Contract Manufacturing (CMO) Market Overview
1.1 Product Overview and Scope of Pharmaceutical Contract Manufacturing (CMO)
1.2 Pharmaceutical Contract Manufacturing (CMO) Market Segmentation by Type
1.2.1 Global Production Market Share of Pharmaceutical Contract Manufacturing (CMO) by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Pharmaceutical Contract Manufacturing (CMO) Market Segmentation by Application
1.3.1 Pharmaceutical Contract Manufacturing (CMO) Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Pharmaceutical Contract Manufacturing (CMO) Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Pharmaceutical Contract Manufacturing (CMO) (2014-2029)
Chapter 2 Global Economic Impact on Pharmaceutical Contract Manufacturing (CMO) Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global Pharmaceutical Contract Manufacturing (CMO) Market Competition by Manufacturers
3.1 Global Pharmaceutical Contract Manufacturing (CMO) Production and Share by Manufacturers (2020 and 2022)
3.2 Global Pharmaceutical Contract Manufacturing (CMO) Revenue and Share by Manufacturers (2020 and 2022)
3.3 Global Pharmaceutical Contract Manufacturing (CMO) Average Price by Manufacturers (2020 and 2022)
3.4 Manufacturers Pharmaceutical Contract Manufacturing (CMO) Manufacturing Base Distribution, Production Area and Product Type
3.5 Pharmaceutical Contract Manufacturing (CMO) Market Competitive Situation and Trends
3.5.1 Pharmaceutical Contract Manufacturing (CMO) Market Concentration Rate
3.5.2 Pharmaceutical Contract Manufacturing (CMO) Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global Pharmaceutical Contract Manufacturing (CMO) Production, Revenue (Value) by Region (2014-2022)
4.1 Global Pharmaceutical Contract Manufacturing (CMO) Production by Region (2014-2022)
4.2 Global Pharmaceutical Contract Manufacturing (CMO) Production Market Share by Region (2014-2022)
4.3 Global Pharmaceutical Contract Manufacturing (CMO) Revenue (Value) and Market Share by Region (2014-2022)
4.4 Global Pharmaceutical Contract Manufacturing (CMO) Production, Revenue, Price and Gross Margin (2014-2022)
4.5 North America Pharmaceutical Contract Manufacturing (CMO) Production, Revenue, Price and Gross Margin (2014-2022)
4.6 Europe Pharmaceutical Contract Manufacturing (CMO) Production, Revenue, Price and Gross Margin (2014-2022)
4.7 China Pharmaceutical Contract Manufacturing (CMO) Production, Revenue, Price and Gross Margin (2014-2022)
4.8 Japan Pharmaceutical Contract Manufacturing (CMO) Production, Revenue, Price and Gross Margin (2014-2022)
4.9 Southeast Asia Pharmaceutical Contract Manufacturing (CMO) Production, Revenue, Price and Gross Margin (2014-2022)
4.10 India Pharmaceutical Contract Manufacturing (CMO) Production, Revenue, Price and Gross Margin (2014-2022)
Chapter 5 Global Pharmaceutical Contract Manufacturing (CMO) Supply (Production), Consumption, Export, Import by Regions (2014-2022)
5.1 Global Pharmaceutical Contract Manufacturing (CMO) Consumption by Regions (2014-2022)
5.2 North America Pharmaceutical Contract Manufacturing (CMO) Production, Consumption, Export, Import by Regions (2014-2022)
5.3 Europe Pharmaceutical Contract Manufacturing (CMO) Production, Consumption, Export, Import by Regions (2014-2022)
5.4 China Pharmaceutical Contract Manufacturing (CMO) Production, Consumption, Export, Import by Regions (2014-2022)
5.5 Japan Pharmaceutical Contract Manufacturing (CMO) Production, Consumption, Export, Import by Regions (2014-2022)
5.6 Southeast Asia Pharmaceutical Contract Manufacturing (CMO) Production, Consumption, Export, Import by Regions (2014-2022)
5.7 India Pharmaceutical Contract Manufacturing (CMO) Production, Consumption, Export, Import by Regions (2014-2022)
Chapter 6 Global Pharmaceutical Contract Manufacturing (CMO) Production, Revenue (Value), Price Trend by Type
6.1 Global Pharmaceutical Contract Manufacturing (CMO) Production and Market Share by Type (2014-2022)
6.2 Global Pharmaceutical Contract Manufacturing (CMO) Revenue and Market Share by Type (2014-2022)
6.3 Global Pharmaceutical Contract Manufacturing (CMO) Price by Type (2014-2022)
6.4 Global Pharmaceutical Contract Manufacturing (CMO) Production Growth by Type (2014-2022)
Chapter 7 Global Pharmaceutical Contract Manufacturing (CMO) Market Analysis by Application
7.1 Global Pharmaceutical Contract Manufacturing (CMO) Consumption and Market Share by Application (2014-2022)
7.2 Global Pharmaceutical Contract Manufacturing (CMO) Consumption Growth Rate by Application (2014-2022)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 Pharmaceutical Contract Manufacturing (CMO) Manufacturing Cost Analysis
8.1 Pharmaceutical Contract Manufacturing (CMO) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Pharmaceutical Contract Manufacturing (CMO)
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Pharmaceutical Contract Manufacturing (CMO) Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Pharmaceutical Contract Manufacturing (CMO) Major Manufacturers in 2020
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global Pharmaceutical Contract Manufacturing (CMO) Market Forecast (2022-2029)
12.1 Global Pharmaceutical Contract Manufacturing (CMO) Production, Revenue Forecast (2022-2029)
12.2 Global Pharmaceutical Contract Manufacturing (CMO) Production, Consumption Forecast by Regions (2022-2029)
12.3 Global Pharmaceutical Contract Manufacturing (CMO) Production Forecast by Type (2022-2029)
12.4 Global Pharmaceutical Contract Manufacturing (CMO) Consumption Forecast by Application (2022-2029)
12.5 Pharmaceutical Contract Manufacturing (CMO) Price Forecast (2022-2029)
Chapter 13 Appendix
Published On:2024/07/06
Base Year:
Historical Data:
No of Pages:165
Price
Global Pharmaceutical Contract Manufacturing (CMO) Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
